mkdir -p /home/daytona/workspace/anki && cat > /home/daytona/workspace/anki/inflammation_anki.txt << 'ANKIEOF' Acute and Chronic Inflammation - Pathology (NEET PG 2027) <b>DEFINITION OF INFLAMMATION</b><br><br>Inflammation is a response of vascularized tissues that delivers leukocytes and molecules of host defense from the circulation to sites of infection and cell damage. It is a protective response that eliminates the initial cause of cell injury (microbes, toxins) and the consequences (necrotic cells). Suffix -itis denotes inflammation at a site (e.g., appendicitis, conjunctivitis).<br><br><b>ACUTE vs CHRONIC INFLAMMATION</b><br><br>Acute inflammation: Rapid onset (minutes to hours), short duration (days), predominantly neutrophilic infiltrate, vascular changes and edema prominent, usually resolves or may progress to chronic. Chronic inflammation: Prolonged duration (weeks to months), mononuclear cell infiltrate (macrophages, lymphocytes, plasma cells), tissue destruction and attempts at repair (fibrosis and angiogenesis) coexist simultaneously. Causes of chronic inflammation: (1) Persistent infections (mycobacteria, fungi, viruses) causing granulomatous reaction, (2) Hypersensitivity diseases - autoimmune (RA, MS) or allergic (asthma), (3) Prolonged exposure to toxic agents (silica causing silicosis, cholesterol in atherosclerosis).<br><br><b>CARDINAL SIGNS OF INFLAMMATION</b><br><br>Five cardinal signs: (1) Rubor (redness) - due to vasodilation, (2) Calor (heat) - due to vasodilation and increased metabolic activity, (3) Tumor (swelling) - due to increased vascular permeability and edema, (4) Dolor (pain) - due to prostaglandins and bradykinin stimulating nerve endings, (5) Functio laesa (loss of function) - due to pain and swelling. First four described by Celsius, fifth by Virchow.<br><br><b>STEPS OF ACUTE INFLAMMATION</b><br><br>Sequential steps: (1) Recognition of noxious agent by tissue sentinel cells (dendritic cells, phagocytes) via pattern recognition receptors, (2) Vascular events - changes in blood flow and permeability, (3) Cellular events - leukocyte recruitment (margination, rolling, adhesion, transmigration), (4) Chemotaxis - directed leukocyte migration, (5) Phagocytosis and clearance, (6) Regulation and termination, (7) Repair.<br><br><b>VASCULAR EVENTS</b><br><br>(A) Early Transient Vasoconstriction: Brief initial vasoconstriction of arterioles lasting only seconds to minutes immediately after injury. Mediated by neurogenic reflexes and chemical mediators.<br><br>(B) Vasodilation: Follows vasoconstriction. Involves arterioles first, then opening of new capillary beds. Results in increased blood flow (hyperemia) causing redness and warmth. Mediated by histamine, nitric oxide, prostaglandins (PGE2, PGI2), bradykinin, neuropeptide substance P. Leads to slowing of blood flow (stasis) in venules as protein-rich fluid exits.<br><br>(C) Increased Vascular Permeability: Allows protein-rich exudate to escape into interstitium. Mechanisms: (1) Endothelial cell contraction forming intercellular gaps in venules - most common mechanism, triggered by histamine, bradykinin, leukotrienes, neuropeptides - immediate transient response. (2) Direct endothelial injury - immediate sustained response from severe injury (burns, toxins). (3) Leukocyte-mediated injury - delayed, prolonged response. (4) Transcytosis via vesicular channels.<br><br><b>EXUDATE vs TRANSUDATE</b><br><br>Exudate: Protein-rich fluid (protein content more than 3 g/dL, specific gravity more than 1.020), contains cells (neutrophils), results from increased vascular permeability in inflammation. Transudate: Protein-poor fluid (less than 3 g/dL, specific gravity less than 1.012), results from increased hydrostatic pressure (heart failure) or decreased osmotic pressure (hypoalbuminemia) - NOT due to inflammation. Key difference: exudate is due to active inflammatory process with endothelial damage; transudate is a passive ultrafiltrate due to hemodynamic imbalance.<br><br><b>STASIS</b><br><br>As vascular dilation and increased permeability progress, blood flow slows - this is called stasis. Due to loss of protein-rich fluid causing increased blood viscosity, engorgement of small vessels. Result: leukocytes redistribute from central axial column to peripheral position along endothelium (margination/pavementing).<br><br><b>CELLULAR EVENTS - MARGINATION AND PAVEMENTING</b><br><br>Normally, red cells occupy central axial column and leukocytes are peripherally displaced. With stasis and slowed flow in postcapillary venules, more leukocytes assume peripheral position along endothelial surface - this is called margination. When many leukocytes line the endothelium, it is called pavementing (resembles pebbles over which a stream runs without disturbing them).<br><br><b>ROLLING</b><br><br>Slowed leukocytes sense signals from the endothelium and begin to roll along the vessel wall (tumbling motion). Mediated by selectins. Rolling is a weak, transient, reversible interaction that brings leukocytes in close contact with endothelium to allow activation.<br><br><b>SELECTINS AND THEIR MEDIATORS</b><br><br>Three types of selectins mediate rolling: (1) L-selectin (CD62L): Expressed on leukocytes (all types), located at tips of microvilli. Ligands: GlyCAM-1, CD34 on endothelium. Constitutively expressed. (2) E-selectin (CD62E): Expressed on endothelium only. Ligand on leukocytes: Sialyl-Lewis X antigen (sialylated oligosaccharides on mucin-like glycoproteins). Induced by TNF-alpha and IL-1 within 1-2 hours. (3) P-selectin (CD62P): Expressed on platelets and endothelium. Ligand: PSGL-1 (P-selectin glycoprotein ligand-1) on leukocytes, also sialylated oligosaccharides. Stored in Weibel-Palade bodies of endothelial cells and alpha-granules of platelets - redistributed to cell surface within minutes by histamine and thrombin stimulation (fastest acting). Summary of distribution: L = Leukocytes, E = Endothelium (induced by cytokines), P = Platelets and Endothelium (preformed, rapidly mobilized). All ligands are sialylated oligosaccharides on mucin-like glycoproteins.<br><br><b>ADHESION - INTEGRINS AND THEIR LIGANDS</b><br><br>Firm adhesion replaces rolling. Mediated by integrins (heterodimeric leukocyte surface proteins) binding to ICAM-1 and VCAM-1 on endothelium. Integrins on leukocytes and their endothelial ligands: (1) LFA-1 (CD11a/CD18) - beta-2 integrin - binds ICAM-1 on endothelium, (2) MAC-1 (CD11b/CD18, also called CR3) - beta-2 integrin - binds ICAM-1 on endothelium. Also functions as complement receptor 3 for C3b opsonin. (3) VLA-4 (CD49d/CD29) - beta-1 integrin - binds VCAM-1 on endothelium. Normally integrins are in LOW affinity state. Chemokines on endothelial surface activate rolling leukocytes and CONVERT integrins to HIGH affinity state. TNF and IL-1 induce endothelial expression of ICAM-1 and VCAM-1. Result: leukocytes stop rolling, cytoskeleton reorganizes, cells spread out on endothelial surface.<br><br><b>TRANSMIGRATION (DIAPEDESIS)</b><br><br>Leukocytes emigrate through endothelium, mainly in postcapillary venules. Process: After firm adhesion, leukocyte extends pseudopods, squeezes between endothelial cells (paracellular) or rarely through endothelial cells (transcellular), then crosses basement membrane aided by collagenase. Key mediators: PECAM-1 (CD31, platelet endothelial cell adhesion molecule) expressed on both leukocytes and endothelial cells - homophilic binding of PECAM-1:PECAM-1 is required for transmigration. Also CD99 (homophilic interactions) mediates transmigration of leukocytes across endothelium. Collagenase from leukocytes helps degrade basement membrane. First cells to emigrate: neutrophils (6-24 hours), then monocytes (24-48 hours).<br><br><b>CHEMOTAXIS - MECHANISM AND MEDIATORS</b><br><br>Chemotaxis is locomotion oriented along a chemical gradient toward the site of inflammation. Mechanism: Chemoattractants bind to 7-transmembrane G-protein coupled receptors on leukocytes, activate phospholipase C leading to IP3 and DAG, increase intracellular Ca2+, activate GTPases (Rac, Rho, Cdc42) causing actin polymerization and pseudopod formation at the leading edge (high chemoattractant concentration end). Leukocyte moves toward higher concentration of chemoattractants. Exogenous chemoattractants: bacterial products - especially N-formylmethionyl peptides (N-formyl-met-leu-phe, fMLP) released by bacteria since bacteria initiate protein synthesis with N-formylmethionine (mammalian cells do not). Endogenous chemoattractants and their sources: (1) C5a - from complement activation (plasma), (2) Leukotriene B4 (LTB4) - from arachidonic acid metabolism via lipoxygenase pathway in leukocytes and mast cells, (3) IL-8 (CXCL8) - chemokine from macrophages, endothelial cells, fibroblasts stimulated by TNF-alpha and IL-1, (4) Various other chemokines - from activated leukocytes, endothelium, and stromal cells. Most potent chemoattractant for neutrophils: LTB4 and IL-8. C5a attracts neutrophils, monocytes, eosinophils, and basophils.<br><br><b>OPSONIZATION AND OPSONINS</b><br><br>Opsonization is the process of coating microbes or particles to enhance phagocytosis. Opsonins are molecules that coat particles. Three main opsonins: (1) IgG (Fc portion) - most important opsonin - binds via Fc gamma receptors (FcgammaRIII = CD16) on phagocytes - antibody-mediated opsonization, (2) C3b (complement fragment) - binds via complement receptor 1 (CR1, CD35) on phagocytes - complement-mediated opsonization. Also iC3b binds CR3 (MAC-1), (3) Lectins (e.g., mannose-binding lectin, MBL, collectins) - bind carbohydrates on microbe surface - bind via collectin receptors. Opsonization dramatically increases phagocytic efficiency - opsonized particles are ingested 1000x faster than unopsonized.<br><br><b>PHAGOCYTOSIS - MECHANISM</b><br><br>Three sequential steps: (1) Recognition and attachment: Phagocyte receptors (Fc receptors, complement receptors CR1/CR3, mannose receptors for terminal mannose/fucose on microbial glycoproteins, scavenger receptors for modified LDL and polyanionic ligands) bind opsonized or non-opsonized particles. (2) Engulfment: Cytoplasmic extensions (pseudopods) flow around the particle, plasma membrane pinches off forming a phagosome. Phagosome fuses with lysosomal granule forming phagolysosome. Process requires actin filament polymerization (cytoskeletal rearrangement). (3) Killing and degradation: (a) Oxygen-dependent: NADPH oxidase assembles in phagosome membrane, produces superoxide anion (O2-), then H2O2. MPO (myeloperoxidase) converts H2O2 + Cl- to hypochlorous acid (HOCl, bleach-like) - most potent microbicidal mechanism in neutrophils. Also NO produced by iNOS combines with O2- to form peroxynitrite (ONOO-). (b) Oxygen-independent: Lysozyme, defensins, lactoferrin, acid hydrolases, cathepsin G, elastase, BPI (bactericidal permeability-increasing protein).<br><br><b>FRUSTRATED PHAGOCYTOSIS</b><br><br>Occurs when phagocytes encounter materials too large to engulf (e.g., immune complexes on large surfaces like glomerular basement membrane, large fungi, asbestos fibers, urate crystals). Leukocytes cannot surround and ingest these substances. Result: strong activation of phagocyte WITHOUT formation of enclosed phagolysosome, leading to release of lysosomal enzymes and ROS into extracellular environment, causing tissue damage. Also occurs when urate crystals damage phagolysosome membrane from within. Examples: Goodpasture syndrome (immune complexes on GBM), SLE nephritis, gout (urate crystals), silicosis (silica particles).<br><br><b>LEUKOCYTE ADHESION DEFICIENCY TYPE 1 (LAD-1)</b><br><br>Inheritance: Autosomal recessive. Pathogenesis: Mutation in CD18 gene encoding beta-2 integrin common chain (also called beta-2 subunit). Beta-2 integrin is shared by LFA-1 (CD11a/CD18) and MAC-1 (CD11b/CD18). Without CD18, these integrins cannot be assembled or expressed on leukocyte surface. Result: leukocytes cannot undergo firm adhesion or transmigration. Clinical presentation: Recurrent severe bacterial and fungal infections (Staph aureus, gram-negative bacteria), delayed separation of umbilical cord (beyond 3 weeks - hallmark), omphalitis, recurrent gingivitis and periodontitis, impaired wound healing, lack of pus formation despite high circulating neutrophils. Lab: Markedly elevated peripheral blood neutrophilia (leukocytosis) because neutrophils cannot leave blood. Absent or reduced CD11/CD18 on flow cytometry. No pus at infection sites despite neutrophilia.<br><br><b>LEUKOCYTE ADHESION DEFICIENCY TYPE 2 (LAD-2)</b><br><br>Inheritance: Autosomal recessive. Pathogenesis: Mutation in GDP-fucose transporter gene (FUCT1) causing defective fucosylation of glycoproteins. Result: absence of sialyl-Lewis X antigen (the selectin ligand on neutrophils required for rolling). Without rolling, leukocytes cannot begin recruitment cascade. Clinical presentation: Similar to LAD-1 but MILDER - recurrent bacterial infections, periodontitis. Additional features: intellectual disability, short stature, Bombay blood group (H antigen absent due to fucosylation defect - unable to make H antigen). Lab: Neutrophilia (mild). Absence of sialyl-Lewis X (CD15s) on neutrophils by flow cytometry. Key difference from LAD-1: LAD-1 affects firm adhesion (integrin defect), LAD-2 affects rolling (selectin ligand defect). LAD-2 is milder and has neurological features.<br><br><b>CHRONIC GRANULOMATOUS DISEASE (CGD)</b><br><br>Inheritance: X-linked (most common, 66%) - mutation in gp91phox gene encoding the large subunit of cytochrome b558 (NOX2 component of NADPH oxidase). Autosomal recessive (33%) - mutations in p22phox, p47phox, p67phox, p40phox genes. Pathogenesis: Defect in NADPH oxidase (phagocyte oxidase) - failure to produce superoxide (O2-) and downstream ROS during respiratory burst. Phagocytes can engulf bacteria but CANNOT kill catalase-positive organisms because these bacteria destroy any H2O2 the phagocyte generates. Organisms that are catalase-NEGATIVE produce their own H2O2 which can be used by MPO - so they are NOT problematic. Susceptible organisms (catalase-positive): Staph aureus, Burkholderia cepacia, Serratia marcescens, Nocardia, Aspergillus (most dangerous fungal pathogen in CGD). Clinical presentation: Recurrent life-threatening bacterial and fungal infections starting in early childhood. Lymphadenopathy, hepatosplenomegaly, hypergammaglobulinemia. Granuloma formation (hallmark) - due to failure to eradicate organisms, leading to chronic inflammation and granulomas that may obstruct vital organs (pyloric outlet obstruction, urinary tract obstruction). Skin abscesses, lymphadenitis, osteomyelitis. Inflammatory bowel disease-like syndrome. Screening test: Dihydrorhodamine (DHR) flow cytometry test (preferred, most sensitive) - measures conversion of DHR to rhodamine 123 by ROS. Normal neutrophils show bright green fluorescence, CGD neutrophils show absent or dim fluorescence. Older test: Nitroblue tetrazolium (NBT) test - normal neutrophils reduce yellow NBT to blue/purple formazan; CGD neutrophils fail to do so (remain yellow). NBT test is positive in normal neutrophils.<br><br><b>CHEDIAK-HIGASHI SYNDROME</b><br><br>Inheritance: Autosomal recessive. Pathogenesis: Mutation in LYST gene (lysosomal trafficking regulator, chromosome 1q42). LYST protein regulates vesicle size - mutation causes failure of normal granule maturation, leading to abnormal enlargement and fusion of granules and vesicles (lysosomes, melanosomes, platelet dense granules) in all cell types. Result: Giant fused lysosomes in leukocytes that cannot properly degranulate and fuse with phagosomes - impaired chemotaxis, degranulation, and intracellular killing. Clinical presentation: (1) Partial oculocutaneous albinism (melanosomes fuse abnormally) - photophobia, nystagmus, silver-gray hair, (2) Recurrent severe bacterial infections (especially pyogenic - Staph, Strep), (3) Peripheral neuropathy and neurologic defects, (4) Giant granules in leukocytes (pathognomonic finding on peripheral smear), (5) Accelerated phase (lymphoma-like) - hemophagocytic lymphohistiocytosis (HLH) with lymphadenopathy, hepatosplenomegaly, pancytopenia, widespread lymphoid infiltrates - fatal if untreated. Lab: Giant granules in neutrophils, eosinophils, monocytes, lymphocytes on peripheral smear. Prolonged bleeding time (platelet dense granule defect). NK cell dysfunction. Treatment: Bone marrow transplant (curative). Neutrophil defects: impaired chemotaxis, impaired degranulation, delayed microbicidal activity.<br><br><b>NEUTROPHIL EXTRACELLULAR TRAPS (NETs)</b><br><br>Goal: Concentrate antimicrobial substances at sites of infection and trap microbes to prevent their spread. Particularly important for trapping large microbes (e.g., fungi like Aspergillus) too large to be phagocytosed. Mechanism: (1) Activation trigger: infectious pathogens (bacteria, fungi) and inflammatory mediators (chemokines, cytokines especially interferons, complement proteins, ROS) stimulate neutrophils. (2) ROS-dependent activation of peptidylarginine deiminase 4 (PAD4) enzyme converts arginines to citrulline in histones, causing chromatin decondensation. (3) MPO and elastase translocate to nucleus causing further chromatin decondensation. (4) Nuclear envelope ruptures and chromatin is released. (5) Cell death occurs (NETosis) - neutrophil loses nucleus and dies. NETs consist of: nuclear chromatin (DNA + histones) embedded with antimicrobial granule proteins (MPO, elastase, defensins, cathepsins, calprotectin). NETs also detected in blood during sepsis. Role in disease: excessive NET formation contributes to thrombosis (found in thrombi in DVT, MI), vasculitis, and SLE (NET-associated DNA and histones can be autoantigens).<br><br><b>EMPERIPOLESIS vs PHAGOCYTOSIS</b><br><br>Emperipolesis: The presence of an intact, viable hematopoietic cell within the cytoplasm of another (usually a histiocyte/macrophage). Key difference from phagocytosis: In emperipolesis the engulfed cell remains INTACT and VIABLE (not being digested), whereas in phagocytosis the engulfed material is degraded and killed within the phagolysosome. In phagocytosis, material is actively killed by ROS and lysosomal enzymes. In emperipolesis, the inner cell survives and can exit the host cell. Conditions where emperipolesis is seen: (1) Rosai-Dorfman Disease (Sinus Histiocytosis with Massive Lymphadenopathy) - MOST classic association - large histiocytes in lymph node sinuses engulf lymphocytes, plasma cells, and red cells intact, histiocytes stain S100-positive and CD68-positive but CD1a-negative. Presents with massive painless cervical lymphadenopathy, fever, leukocytosis, elevated ESR, polyclonal hypergammaglobulinemia. (2) Myeloma (plasma cells may show emperipolesis). (3) Hemophagocytic lymphohistiocytosis (HLH) - though true phagocytosis occurs (hemophagocytosis) the terms are sometimes used together. Classic emperipolesis is Rosai-Dorfman disease. ANKIEOF echo "File written. Checking line count:" wc -l /home/daytona/workspace/anki/inflammation_anki.txt

python3 -c " with open('/home/daytona/workspace/anki/inflammation_anki.txt', 'r') as f: content = f.read() # Check for forbidden characters import re tab_count = content.count('\t') newline_count = content.count('\n') pipe_count = content.count('|') semicolon_count = content.count(';') print(f'Tabs: {tab_count}') print(f'Newlines: {newline_count}') print(f'Pipes: {pipe_count}') print(f'Semicolons: {semicolon_count}') # Split on tab to get front and back parts = content.strip().split('\t') print(f'Number of TAB-separated parts: {len(parts)}') print(f'Front: {parts[0][:80]}') print(f'Back starts with: {parts[1][:100] if len(parts) > 1 else \"NO BACK\"}') print(f'Total characters: {len(content)}') "

python3 -c " with open('/home/daytona/workspace/anki/inflammation_anki.txt', 'r') as f: content = f.read() # Find lines with semicolons for i, line in enumerate(content.split('\n')): if ';' in line: idx = line.index(';') print(f'Line {i}, position {idx}: ...{line[max(0,idx-60):idx+60]}...') "

python3 -c " with open('/home/daytona/workspace/anki/inflammation_anki.txt', 'r') as f: content = f.read() # Replace all semicolons with commas content_fixed = content.replace(';', ',') # Verify semicolon_count = content_fixed.count(';') print(f'Semicolons after fix: {semicolon_count}') with open('/home/daytona/workspace/anki/inflammation_anki.txt', 'w') as f: f.write(content_fixed) print('Done') " wc -l /home/daytona/workspace/anki/inflammation_anki.txt